Nurix Therapeutics Reports Third Quarter Fiscal 2020 Financial Results and Provides a Corporate Update Portfolio News / By Karina Tin October 14, 2020
A2 Biotherapeutics Closes $71.5M Series B to Begin Clinical Development of its Potentially Transformative Selective Tumor Cell Therapeutics Portfolio News / By Karina Tin October 6, 2020
Arcus Biosciences: Jennifer Jarrett Returns as Chief Operating Officer Portfolio News / By Karina Tin October 1, 2020
Carmot Therapeutics Expands Leadership Team and Closes $47M Series C Financing to Advance Novel Incretin Receptor Modulators Through Phase 2 Studies Portfolio News / By Karina Tin September 30, 2020
Synthekine Launches with $82 Million Series A Financing to Advance Pipeline of Engineered Cytokine Therapeutics Optimized for Cancer and Autoimmune Diseases Portfolio News / By Karina Tin September 17, 2020
Revolution Medicines Reports Preclinical Tumor Regressions Induced by First-in-Class KRAS-G12D(ON) Inhibitors Portfolio News / By Karina Tin September 16, 2020
Hexagon Bio Closes $47 Million in Series A Financing to Advance Novel Oncology and Infectious Disease Therapies Portfolio News / By Karina Tin September 15, 2020
Hexagon Bio: This Biotech Startup Just Raised $47 Million To Make Drugs From Fungi Portfolio News / By Karina Tin September 15, 2020
Hexagon Bio Closes $47 Million in Series A Financing to Advance Novel Oncology and Infectious Disease Therapies Portfolio News / By Karina Tin September 15, 2020
Escient Pharmaceuticals Raises $77.5 Million Series B Round And Initiates A Phase 1/1b Clinical Trial Of EP547, A MRGPR-Targeted Therapy To Treat Cholestatic And Uremic Pruritus Portfolio News / By Karina Tin September 14, 2020